A. Sabrkhany

Antunes-Ferreira, M., D'Ambrosi, S., Arkani, M., Post, E., In 't Veld, S. G. J. G., Ramaker, J., Zwaan, K., Kucukguzel, E. D., Wedekind, L. E., Griffioen, A. W., Egbrink, M. O., Kuijpers, M. J. E., van den Broek, D., Noske, D. P., Hartemink, K. J., Sabrkhany, S., Bahce, I., Sol, N., Bogaard, H.-J., ... Wurdinger, T. (2023). Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management. Scientific Reports, 13(1), Article 9359. https://doi.org/10.1038/s41598-023-35818-w

Sabrkhany, S., Kuijpers, M. J. E., Van Kuijk, S. M. J., Griffioen, A. W., & Oude Egbrink, M. G. A. (2023). Age- and gender-matched controls needed for platelet-based biomarker studies. Haematologica-the Hematology Journal, 108(6), 1667-1670. https://doi.org/10.3324/haematol.2022.281726

In 't Veld, S. G. J. G., Arkani, M., Post, E., Antunes-Ferreira, M., D'Ambrosi, S., Vessies, D. C. L., Vermunt, L., Vancura, A., Muller, M., Niemeijer, A.-L. N., Tannous, J., Meijer, L. L., Le Large, T. Y. S., Mantini, G., Wondergem, N. E., Heinhuis, K. M., van Wilpe, S., Smits, A. J., Drees, E. E. E., ... Wurdinger, T. (2022). Detection and localization of early- and late-stage cancers using platelet RNA. Cancer Cell, 40(9), 999-1009.e6. https://doi.org/10.1016/j.ccell.2022.08.006

Tullemans, B. M. E., Brouns, S. L. N., Swieringa, F., Sabrkhany, S., van den Berkmortel, F. W. P. J., Peters, N. A. J. B., de Bruijn, P., Koolen, S. L. W., Heemskerk, J. W. M., Aarts, M. J. B., & Kuijpers, M. J. E. (2022). Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study. BMC Cancer, 22(1), Article 653. https://doi.org/10.1186/s12885-022-09676-0

de Bont, E., Broers, N., Muris, D., Wynants, L., Leers, M., Schoorel, E., Cals, J. W. L., Sabrkhany, S., Bergmans, P., Bruls, B., Eurelings, R., & Laven, R. (2022). Opschalen naar een bovenregionale 24/7-HAP bij de COVID-19-pandemie. Huisarts en Wetenschap, 65(3), 43-46. https://doi.org/10.1007/s12445-022-1395-0

D'Ambrosi, S., Visser, A., Antunes-Ferreira, M., Poutsma, A., Giannoukakos, S., Sol, N., Sabrkhany, S., Bahce, I., Kuijpers, M. J. E., Egbrink, M. G. A. O., Griffioen, A. W., Best, M. G., Koppers-Lalic, D., Oudejans, C., & Wurdinger, T. (2021). The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer. Cancers, 13(18), Article 4644. https://doi.org/10.3390/cancers13184644

Walraven, M., Sabrkhany, S., Knol, J. C., Dekker, H., de Reus, I., Piersma, S. R., Pham, T., Griffioen, A. W., Broxterman, H. J., Egbrink, M. O., Verheul, H. M. W., & Jimenez, C. R. (2021). Effects of Cancer Presence and Therapy on the Platelet Proteome. International journal of molecular sciences, 22(15), Article 8236. https://doi.org/10.3390/ijms22158236

Sabrkhany, S., Kuijpers, M. J. E., Egbrink, M. G. A. O., & Griffioen, A. W. (2021). Platelets as messengers of early-stage cancer. Cancer and Metastasis Reviews, 40(2), 563-573. https://doi.org/10.1007/s10555-021-09956-4

Sabrkhany, S., Kuijpers, M. J. E., Griffioen, A. W., & Egbrink, M. G. A. O. (2019). Platelets: the holy grail in cancer blood biomarker research? Angiogenesis, 22(1), 1-2. https://doi.org/10.1007/s10456-018-9651-4

Tullemans, B. M. E., Nagy, M., Sabrkhany, S., Griffioen, A. W., Egbrink, M. G. A. O., Aarts, M., Heemskerk, J. W. M., & Kuijpers, M. J. E. (2018). Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients. Frontiers in Cardiovascular Medicine, 5, Article 142. https://doi.org/10.3389/fcvm.2018.00142